Search
Search
ASRS: 2025
Kenneth C. Fan, MD, MBA
Show Description +
Dr. Fan shares updates from the TEASE-3 trial of oral gildeuretinol (ALK-001, Alkeus); data show that treatment slows disease progression in early Stargardt disease.
Posted: 8/06/2025
Kenneth C. Fan, MD, MBA
Dr. Fan shares updates from the TEASE-3 trial of oral gildeuretinol (ALK-001, Alkeus); data show that treatment slows disease progression in early Stargardt disease.
Posted: 8/06/2025
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2025.
Please log in to leave a comment.